| Name | 4-chloro-N'-hydroxy-3-nitrobenzenecarboximidamide |
|---|---|
| Synonyms |
4-Chloro-N-hydroxy-3-nitrobenzenecarboximidamide
4-Chloro-3-nitrobenzamideoxime 4-chloro-N'-hydroxy-3-nitrobenzenecarboximideamide 4-chloro-n-hydroxy-3-nitro-benzamidine (Z)-4-chloro-N'-hydroxy-3-nitrobenzamidine |
| Density | 1.656g/cm3 |
|---|---|
| Boiling Point | 421.1ºC at 760 mmHg |
| Molecular Formula | C7H6ClN3O3 |
| Molecular Weight | 215.59400 |
| Flash Point | 208.474ºC |
| Exact Mass | 215.01000 |
| PSA | 104.43000 |
| LogP | 2.56620 |
| Index of Refraction | 1.665 |
| HS Code | 2925290090 |
|---|
|
~99%
96898-75-8 |
| Literature: BAYER HEALTHCARE AG Patent: WO2005/72741 A1, 2005 ; Location in patent: Page/Page column 23 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2925290090 |
|---|---|
| Summary | 2925290090 other imines and their derivatives; salts thereof。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |